News tagged adverse-drug-events

DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions

Topics: Controlled substances and Dea

Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.

Read More →

Nominations for 2014 NABP Annual Awards Now Being Accepted

NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.

Read More →

FDA Provides New Information About Lack of Sterility Assurance for Drugs Dispensed by The Compounding Shop

Topics: Compounding, Adverse drug events, and Fda

Food and Drug Administration (FDA) is warning patients and health care providers that budesonide solution (for nasal irrigation), dispensed by The Compounding Shop of St Petersburg, FL, may be contaminated and should not be used or administered to patients. 

Read More →

FDA Requires Changes to Fentanyl Pain Patch Warnings

Topics: Adverse drug events and Fda

To reduce the risk of accidental exposure, FDA has announced new requirements that change the appearance of fentanyl pain patch warnings to make them more visible. 

Read More →

FDA Observes 20 Years of Supporting Medication Safety Through MedWatch Program

Topics: Adverse drug events

For 20 years, FDA’s MedWatch program has supported medication safety efforts by providing a means for health care providers and consumers to report safety information regarding FDA-regulated products. 

Read More →

Fentanyl Patches Should Be Stored and Disposed of Properly to Avoid Accidental Poisonings in Children

Topics: Patient safety and Adverse drug events

Fentanyl patches should be securely stored out of the sight and reach of children and disposed of properly, advises Food and Drug Administration (FDA).

Read More →

FDA Issues New Guidelines for Sleep Aids Containing Zolpidem

Topics: Adverse drug events

FDA has issued new dosing recommendations for sleep aids containing zolpidem.

Read More →

Emergency Room Pharmacists Help Reduce Medication Errors

Topics: Adverse drug events

recent study conducted by Winchester Medical Center in Winchester, VA, shows that involving pharmacists and pharmacy technicians in the hospital admissions process reduced medication errors.

Read More →

Rare Cases of Burns Associated with OTC Topical Muscle and Joint Pain Relievers, FDA Warns

Topics: Federal regulations and Adverse drug events

FDA alerts the public that certain over-the-counter (OTC) products that are applied to the skin for the relief of mild muscle and joint pain have been reported to cause rare cases of serious skin injuries. These OTC topical muscle and...

Read More →

Severe Health Risks Associated With Use of Reumofan Supplement Products, FDA Warns

Topics: Controlled substances, Federal regulations, and Adverse drug events

Food and Drug Administration (FDA) warns that consumers should not use Reumofan Plus products due to serious health risks related to the presence of prescription drug ingredients not listed on product labels. In a news release, FDA explains that the...

Read More →

Reumofan Plus Recalled, FDA Notifies Consumers Using the Product to Consult a Health Care Provider

Topics: Internet pharmacy, Patient safety, and Adverse drug events

FDA issued a safety alert notifying consumers about the recall of Reumofan Plus, a product marketed as a natural dietary supplement for pain relief and other serious conditions. The product contains several active pharmaceutical ingredients not listed on the label...

Read More →

Ohio News: Accidental Drug Poisonings in Ohio

Topics: Adverse drug events and Drug poisoning

Published in the November 2009 Ohio State Board of Pharmacy Newsletter The Ohio Department of Health (ODH) compiles statistics on many different health-related topics every year and tries to monitor trends so that action can be taken when needed. Just...

Read More →